A pilot study showing a stronger H1N1 influenza vaccination response during pregnancy in women who subsequently deliver preterm

Sandra Andorf, Sanchita Bhattacharya, Brice Gaudillière, Gary M. Shaw, David K. Stevenson, Atul J. Butte, Marina SirotaJournal of Reproductive Immunology 2019 · DOI

Introduction

Preterm birth (PTB), defined as delivery before 37 weeks of gestation, remains a leading cause of neonatal mortality and morbidity, affecting approximately 12% of births in the United States. While the etiology of PTB is multifactorial, maternal immune dysregulation and inflammatory "misfires" are increasingly recognized as critical triggers. This pilot study, published in the Journal of Reproductive Immunology, investigates whether the magnitude of a pregnant woman's immune response to a routine influenza vaccination can serve as a biological marker for PTB risk. By treating the vaccine as a standardized "stress test" for the immune system, researchers aimed to identify underlying predispositions to the inflammatory pathways that initiate early labor.

Methods

The researchers performed a secondary analysis of individual-level clinical data from the ImmPort data repository (studies SDY36 and SDY37), funded by the National Institute of Allergy and Infectious Diseases (NIAID). The cohort included 102 pregnant women, of whom 91 delivered at term and 11 delivered preterm.

Participants received a standard seasonal trivalent inactivated vaccination (TIV). The primary outcome measure was the Hemagglutination Inhibition (HAI) assay titer, which quantifies antibody concentrations. The "vaccine response" was calculated as the fold-change between pre-vaccination and post-vaccination (4–8 weeks later) HAI titers for influenza A strains H1N1 and H3N2. Statistical analyses included subset controls for the trimester of vaccination to ensure consistency.

Key Results

The study revealed a significant divergence in immune reactivity between the two groups, specifically regarding the H1N1 strain.

  • Strain-Specific Hyper-Response: Women who subsequently delivered preterm exhibited a significantly higher fold-change in HAI titers for H1N1 compared to those who delivered at term ($P < 0.001$). In contrast, no significant difference was observed in the response to the H3N2 strain ($P = 0.97$).
  • Seroconversion Rates: For the H1N1 strain, 90.1% of the preterm group achieved seroconversion (defined as a $\ge$4-fold increase in titers), compared to only 57.3% of the term group.
  • Robustness of Findings: The association between a high H1N1 response and PTB remained significant even when controlling for the timing of vaccination during pregnancy.
Comparison of HAI response (post/pre-vaccination titer) for H1N1 and H3N2 strains between preterm and term delivery groups.

Discussion

The findings support a "hyper-response" hypothesis, suggesting that an overactive maternal immune system—while potentially providing superior viral protection—may lower the threshold for the inflammatory cascade that triggers labor. The lack of correlation with the H3N2 strain may be due to its lower general immunogenicity or the possibility that H1N1 specifically activates inflammatory pathways more closely linked to the mechanisms of PTB.

Furthermore, the preterm group showed a higher incidence of preeclampsia (36.4% vs 6.6%), another condition rooted in systemic inflammation, reinforcing the link between heightened immune readiness and adverse pregnancy outcomes.

Limitations and Future Directions

As a pilot study, the research is limited by a small sample size of preterm cases ($n=11$) and the nature of secondary data analysis, which precluded the measurement of specific inflammatory cytokines (e.g., IL-6, TNF-$\alpha$) at the time of vaccination. It remains to be determined whether the robust vaccine response is a direct cause of PTB or a marker of a shared underlying inflammatory phenotype. Future prospective studies with larger cohorts are necessary to validate these findings and explore the potential for using vaccine response patterns as an early-warning system for preterm birth risk.

Summary updated

BibTeX
@article{andorf2019pilot,
  author = {Sandra Andorf and Sanchita Bhattacharya and Brice Gaudillière and Gary M. Shaw and David K. Stevenson and Atul J. Butte and Marina Sirota},
  title = {{A pilot study showing a stronger H1N1 influenza vaccination response during pregnancy in women who subsequently deliver preterm}},
  journal = {Journal of Reproductive Immunology},
  year = {2019},
  doi = {10.1016/j.jri.2019.02.004},
}
Figure